Holen Sie sich die Stockscreener-App
21.53
0.09%
0.02
Handel nachbörslich:
21.58
0.05
+0.23%
Avadel Pharmaceuticals Plc Aktie (AVDL) Neueste Nachrichten
Form 8.3•Avadel Pharmaceuticals plc - The Manila Times
Understanding the Setup: (AVDL) and Scalable Risk - Stock Traders Daily
Avadel Sets Court Date for Alkermes Acquisition Scheme - TipRanks
Avadel Pharmaceuticals Announces Court Hearing for Acquisition - TradingView — Track All Markets
Avadel (NASDAQ: AVDL) moves Alkermes acquisition forward with Irish court hearing date - Stock Titan
State Street Increases Stake in Avadel Pharmaceuticals by 2.39% - Intellectia AI
BlackRock discloses 6.94% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Janus Henderson discloses 1.87% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Morgan Stanley discloses trading activity in Avadel Pharmaceuticals shares By Investing.com - Investing.com Nigeria
Bank of America discloses 1.3% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Bank of America discloses 2.39% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
TIG Advisors discloses 4.18% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
BlackRock discloses 6.94% stake in Avadel Pharmaceuticals - Investing.com
Goldman Sachs discloses trading position in Avadel Pharmaceuticals - Investing.com
Goldman Sachs discloses trading position in Avadel Pharmaceuticals By Investing.com - Investing.com South Africa
Janus Henderson discloses 1.87% stake in Avadel Pharmaceuticals - Investing.com India
Bank of America discloses 1.3% stake in Avadel Pharmaceuticals - Investing.com India
Morgan Stanley discloses trading activity in Avadel Pharmaceuticals shares - Investing.com India
UBS O’Connor discloses 1.1% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
BlackRock discloses 6.92% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Bank of America discloses 1.32% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Morgan Stanley discloses trading in Avadel Pharmaceuticals shares By Investing.com - Investing.com Nigeria
Morgan Stanley Capital Services discloses Avadel Pharmaceuticals dealings By Investing.com - Investing.com Nigeria
Avadel Pharmaceuticals shareholders approve $2.37B takeover bid - The Business Journals
Sentiment Review: Can Annovis Bio Inc disrupt its industryBond Market & Weekly Setup with High ROI Potential - baoquankhu1.vn
UBS O’Connor discloses 1.1% stake in Avadel Pharmaceuticals - Investing.com India
BlackRock discloses 6.92% stake in Avadel Pharmaceuticals - Investing.com
Avadel Pharmaceuticals PLC. $AVDL Position Decreased by Wealth Effects LLC - MarketBeat
Morgan Stanley discloses dealings in Avadel Pharmaceuticals shares By Investing.com - Investing.com South Africa
Morgan Stanley discloses dealings in Avadel Pharmaceuticals shares - Investing.com India
FIL Limited discloses 3.14% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
BlackRock discloses 6.93% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Goldman Sachs Asset Management reduces stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Bank of America discloses 1.43% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
BlackRock discloses 6.93% stake in Avadel Pharmaceuticals - Investing.com
3.24%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):